- Google Scholar

Web Images Videos Maps News Shopping Gmail more »

Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration: …

- ►prsjournal.com
F Ziemssen, S Grisanti, KU Bartz-Schmidt, MS … - Drugs &# 38; Aging, 2009 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . 295 1. Approved Indications of Bevacizumab. . . . . . . . . . . . ...
Cited by 1 - Related articles - All 7 versions

Go to Google Home - About Google - About Google Scholar


Scholar	Results 1 - 1 of 1 citing McGimpsey: Treatment of macular degeneration-controversy and hope. (0.07 sec)